Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - nonacog gamma - powder and solvent for solution for injection - 1000unit

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - nonacog gamma - powder and solvent for solution for injection - 2000unit

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - nonacog gamma - powder and solvent for solution for injection - 3000unit

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

lupin healthcare (uk) ltd - levonorgestrel - oral tablet - 1.5mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - irinotecan hydrochloride trihydrate liposomal pegylated - solution for infusion - 5mg/1ml

Stati Uniti - Ingliż - NLM (National Library of Medicine)

sukhtian-htm ( households & toiletries mfg.co) - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 70 ml in 100 ml - antiseptic • for handwashing to decrease bacteria on the skin. • recommended for repeated use.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydralazine hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; purified talc; disodium edetate; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; iron oxide yellow; macrogol 4000; erythrosine - this product accepted for registration as 'currently supplied' at the time of commencement of the act. amended product information (variation to pregnancy statement) was approved as specified in the letter of 13 august 92 from dr bijoy varma. indications as at 28 november 2001 : hypertension (drug resistant, moderate to severe): as supplementary medication for use together with other antihypertensives such as "beta"-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.

Iżrael - Ingliż - Ministry of Health

astrazeneca (israel) ltd - exenatide - powder and solvent for suspension for injection - exenatide 2 mg - exenatide - bydureon is indicated in adults 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose-lowering medicinal products including basal insulin, when the therapy in use, together with diet and exercise, does not provide adequate glycaemic control .

Singapor - Ingliż - HSA (Health Sciences Authority)

reckitt benckiser (singapore) pte ltd - obstetrics & gynaecology - the intended use of this device is for contraception and when properly used, help to prevent pregnancy and reduce the risk of contracting hiv and other sexually transmitted diseases.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

life together co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - sterilization and disinfection for hands and the skin pump an appropriate amount on to the hands and rub together until dry